InvestorsHub Logo
Followers 1
Posts 140
Boards Moderated 0
Alias Born 01/26/2017

Re: None

Monday, 11/06/2017 1:34:19 PM

Monday, November 06, 2017 1:34:19 PM

Post# of 16885
ouch ALKS.. Sen Kamala Harris out looking for scalps.. may explain why ALKS CEO during opiate panel took pains to state that antagonists not the only treatment modality that is valid...he knew this was coming no doubt

https://www.harris.senate.gov/content/senator-harris-launches-investigation-pharmaceutical-manufacturer-alkermes-regarding-opioid

ALKS has the cash to buy TTNP & possibly US licence from Braeburn (if sales are bad this quarter) & promote both antagonist and agonist therapy as well as to broaden the scope of proneura delivery system for other indications.. in any case ALKS has the manufacturing capacity in Ireland to competitively roll out this technology.. for sure in EU & elsewhere
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TTNP News